WHO Updates List of Essential Medication for 2019
The World Health Organization (WHO) has updated the WHO Model List of Essential Medicines for 2019.
Oncology
FDA Approves Novel Therapy for Relapsed, Refractory Multiple Myeloma
Continued approval of Xpovio for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.
Fluorouracil Injection Recalled Due to Glass Particulate
No reports of adverse events have been received at this time, as per the Company.
Biosimilar Zirabev Gets FDA Approval for 5 Types of Cancer
The FDA has approved Zirabev (bevacizumab-bvzr; Pfizer), a biosimilar to Avastin (bevacizumab; Genentech).
Number of Cancer Survivors Set to Top 22 Million by 2030
The number of cancer survivors is projected to increase to more than 22.1 million by Jan. 1, 2030, based on growth and aging of the population alone.
Emotionally Responsive Virtual Coach Helps Address Patient Concerns in New Simulation
Kognito, a health simulation company, is applying its simulation technology to patient education, to address a gap in patient knowledge.
Chemobrain: Experts Weigh in on Very Real — and Growing — Problem
Clinicians should know that chemotherapy-induced cognitive impairment, chemobrain, chemofog, or whatever you want to call it is a real phenomenon.
WHO Report Raises Questions About R&D-Cost Rationale for High Cancer Drug Prices
An analysis conducted by the World Health Organization concluded that R&D costs do not provide enough evidence to justify high prices for cancer drugs.
NSAIDs in Head and Neck Cancer Bring New Meaning to Precision Medicine
Patients with PIK3CA-altered head and neck cancers lived longer if they took NSAIDs, suggesting old drugs may have new clinical uses.
Guide Dogs and White Canes: Navigating Patients, Families Through Cancer at Their Pace
A reflection on how nurses guide patients and their families through the cancer journey.
Next post in Medicine
